Transparency Directive

Alliance Pharma PLC
19 December 2006


For immediate release                                          19 December 2006

Alliance Pharma plc
(the 'Company')

Voting Rights and Capital


In conformity with the Transparency Directive's transitional provision 6 we
would like to notify the market of the following:

The Company's capital consists of 162,061,773 ordinary shares of 1p each with
voting rights. The Company holds no ordinary shares in Treasury.

Therefore, the total number of voting rights in Alliance Pharma plc is
162,061,773

The above figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, Alliance Pharma plc under the
FSA's Disclosure and Transparency Rules.

For further information:


Alliance Pharma plc                                      + 44 (0) 1249 466966

John Dawson, Chief Executive
Maddy Scott, Finance Director
www.alliancepharma.co.uk

Buchanan Communications                                  + 44 (0) 20 7466 5000

Lisa Baderoon




                      This information is provided by RNS
            The company news service from the London Stock Exchange